Murine Microenvironment Metaprofiles Associate with Human Cancer Etiology and Intrinsic Subtypes

Radiation Oncology, New York University School of Medicine.
Clinical Cancer Research (Impact Factor: 8.72). 01/2013; 19(6). DOI: 10.1158/1078-0432.CCR-12-3554
Source: PubMed


Ionizing radiation is a well-established carcinogen in rodent models and a risk factor associated with human cancer. We developed a mouse model that captures radiation effects on host biology by transplanting unirradiated Trp53-null mammary tissue to sham or irradiated hosts. Gene expression profiles of tumors that arose in irradiated mice are distinct from those that arose in naïve hosts. We asked whether expression metaprofiles could discern radiation-preceded human cancer or be informative in sporadic breast cancers.

Experimental design:
Affymetrix microarray gene expression data from 56 Trp53-null mammary tumors were used to define gene profiles and a centroid that discriminates tumors arising in irradiated hosts. These were applied to publicly available human cancer datasets.

Host irradiation induces a metaprofile consisting of gene modules representing stem cells, cell motility, macrophages, and autophagy. Human orthologs of the host irradiation metaprofile discriminated between radiation-preceded and sporadic human thyroid cancers. An irradiated host centroid was strongly associated with estrogen receptor-negative breast cancer. When applied to sporadic human breast cancers, the irradiated host metaprofile strongly associated with basal-like and claudin-low breast cancer intrinsic subtypes. Comparing host irradiation in the context of TGF-β levels showed that inflammation was robustly associated with claudin-low tumors.

Detection of radiation-preceded human cancer by the irradiated host metaprofile raises possibilities of assessing human cancer etiology. Moreover, the association of the irradiated host metaprofiles with estrogen receptor-negative status and claudin-low subtype suggests that host processes similar to those induced by radiation underlie sporadic cancers.

Download full-text


Available from: Mary Helen Barcellos-Hoff, Jan 24, 2014
1 Follower
17 Reads
    • "Similar characterizations have not yet been reported for solid tumors (with the exception of minimal data on mammary cancer Imaoka et al., 2007; Illa-Bochaca et al., 2014a), but may reveal radiation signatures or even radiation quality signatures. For example the gene expression profile of Trp53 null mammary tumors arising in irradiated mice compared to controls can cluster not only human breast cancers into prognostic subtypes but can also cluster radiation-preceded from spontaneous human thyroid cancers and sarcomas (Nguyen et al., 2013). Such signatures could have profound implications on human radiation epidemiology studies because they may be used to distinguish radiogenic tumors from spontaneous tumors of the same histology. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cancer is an important long-term risk for astronauts exposed to protons and high-energy charged particles during travel and residence on asteroids, the moon, and other planets. NASA's Biomedical Critical Path Roadmap defines the carcinogenic risks of radiation exposure as one of four type I risks. A type I risk represents a demonstrated, serious problem with no countermeasure concepts, and may be a potential "show-stopper" for long duration spaceflight. Estimating the carcinogenic risks for humans who will be exposed to heavy ions during deep space exploration has very large uncertainties at present. There are no human data that address risk from extended exposure to complex radiation fields. The overarching goal in this area to improve risk modeling is to provide biological insight and mechanistic analysis of radiation quality effects on carcinogenesis. Understanding mechanisms will provide routes to modeling and predicting risk and designing countermeasures. This white paper reviews broad issues related to experimental models and concepts in space radiation carcinogenesis as well as the current state of the field to place into context recent findings and concepts derived from the NASA Space Radiation Program. Copyright © 2015 The Committee on Space Research (COSPAR). Published by Elsevier Ltd. All rights reserved.
    07/2015; 6:92-103. DOI:10.1016/j.lssr.2015.07.006
  • Source
    • "Since tumors arising in irradiated hosts were not enriched in a particular tumor subtype, the gene lists that define tumors arising in irradiated hosts can be considered metaprofiles that overlay intrinsic subtype. To test the relevance of this model to human cancer, the human homolog of genes that discriminated between tumors arising in irradiated vs non-irradiated mice was applied to radiation-preceded thyroid cancers and radiotherapy-associated sarcomas, both of which were segregated from sporadic cancers using the murine genes associated with tumors arising in irradiated hosts [37]. Using this approach on compiled datasets of profiles from sporadic breast cancers revealed significant clustering of ER-negative, basal-like breast cancers. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This review focuses on recent experimental and modeling studies that attempt to define the physiological context in which high linear energy transfer (LET) radiation increases epithelial cancer risk and the efficiency with which it does so. Radiation carcinogenesis is a two-compartment problem: ionizing radiation can alter genomic sequence as a result of damage due to targeted effects (TE) from the interaction of energy and DNA; it can also alter phenotype and multicellular interactions that contribute to cancer by poorly understood non-targeted effects (NTE). Rather than being secondary to DNA damage and mutations that can initiate cancer, radiation NTE create the critical context in which to promote cancer. Systems biology modeling using comprehensive experimental data that integrates different levels of biological organization and time-scales is a means of identifying the key processes underlying the carcinogenic potential of high-LET radiation. We hypothesize that inflammation is a key process, and thus cancer susceptibility will depend on specific genetic predisposition to the type and duration of this response. Systems genetics using novel mouse models can be used to identify such determinants of susceptibility to cancer in radiation sensitive tissues following high-LET radiation. Improved understanding of radiation carcinogenesis achieved by defining the relative contribution of NTE carcinogenic effects and identifying the genetic determinants of the high-LET cancer susceptibility will help reduce uncertainties in radiation risk assessment.
    Journal of Radiation Research 03/2014; 55 Suppl 1(Suppl 1):i145-i154. DOI:10.1093/jrr/rrt211 · 1.80 Impact Factor
  • Source
    • "The role of metabolic disturbances is becoming evident in non-cancer effects (Tapio 2013) and should be clarified in carcinogenesis (Maddocks et al 2013). • In cancer research, the possibility that low dose ionising radiation might be able to convert normal stem cells into cancer stem cells needs to be explored (Hess et al 2011, Nguyen et al 2013). • Recent studies reveal that epigenetic modifications are involved in cellular reprogramming through changes in gene expression (Dickey et al 2011, Ilnytskyy and Kovalchuk 2011, Tamminga and Kovalchuk 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The fourth workshop of the Multidisciplinary European Low Dose Initiative (MELODI) was organised by STUK-Radiation and Nuclear Safety Authority of Finland. It took place from 12 to 14 September 2012 in Helsinki, Finland. The meeting was attended by 179 scientists and professionals engaged in radiation research and radiation protection. We summarise the major scientific findings of the workshop and the recommendations for updating the MELODI Strategic Research Agenda and Road Map for future low dose research activities.
    Journal of Radiological Protection 06/2013; 33(3):589-603. DOI:10.1088/0952-4746/33/3/589 · 1.70 Impact Factor
Show more